JCI-accredited hospitals · 45+ hospitals & clinics · Patients from 90+ countries · 24/7 multilingual coordination
Article

Lysosomal storage disorder in newborns symptoms

2 min read
Published by Acibadem Health Point Last updated June 5, 2025

Lysosomal storage disorder in newborns symptoms

Lysosomal storage disorder in newborns symptoms Lysosomal storage disorders (LSDs) are a group of rare, inherited metabolic conditions caused by deficiencies in specific enzymes necessary for breaking down complex molecules within the body’s lysosomes. These microscopic structures act as the cell’s recycling centers, digesting and removing waste products. When these enzymes are absent or defective, substances accumulate in the cells, leading to cellular dysfunction and damage across various organs. Detecting these disorders early, especially in newborns, is crucial for managing symptoms and improving quality of life.

Lysosomal storage disorder in newborns symptoms In newborns, the symptoms of lysosomal storage disorders can vary widely depending on the specific type of disorder and the organs affected. Often, symptoms emerge within the first few months of life, although some forms may manifest later. Common early signs include failure to thrive, meaning the baby does not gain weight or grow as expected. This can be accompanied by poor feeding, irritability, or lethargy, which are non-specific but warrant medical attention.

Lysosomal storage disorder in newborns symptoms Another hallmark is developmental delay or regression, where infants may miss important milestones such as sitting, crawling, or smiling, or may lose previously acquired skills. Muscle weakness or poor muscle tone (hypotonia) is frequent, affecting movements and feeding. Enlarged organs, such as the liver (hepatomegaly) and spleen (splenomegaly), are also notable features, often causing abdominal distension that can be palpable during examination.

Lysosomal storage disorder in newborns symptoms Many lysosomal storage disorders involve neurological symptoms due to the accumulation of substances in the brain. These may include seizures, abnormal eye movements, or progressive neurodegeneration. In some disorders, vision problems such as clouding of the cornea or retinal degeneration can be early indicators. Hearing loss and respiratory issues may also be present, especially if the disorder affects the respiratory tract or middle ear.

Skin abnormalities can sometimes be seen, depending on the specific disorder. For instance, in Fabry disease or Gaucher disease, characteristic skin rashes or deposits might appear. Additionally, skeletal abnormalities, such as joint stiffness or deformities, can develop over time, further impairing mobility and causing discomfort.

Early diagnosis relies on a combination of clinical suspicion and laboratory testing. Newborn screening programs, where available, can detect certain LSDs shortly after birth through heel prick blood tests. Confirmatory diagnosis involves enzyme activity assays, genetic testing, and sometimes tissue biopsies. Recognizing the constellation of symptoms early is essential because some lysosomal storage disorders can be treated with enzyme replacement therapy, substrate reduction therapy, or other emerging treatments that can slow disease progression and improve outcomes. Lysosomal storage disorder in newborns symptoms

Lysosomal storage disorder in newborns symptoms In conclusion, while lysosomal storage disorders are complex and varied, awareness of their early symptoms in newborns is vital. Prompt diagnosis can open the door to interventions that may mitigate severe complications, enhance quality of life, and provide families with vital information and support.

We’re With You at Every Step

How can we help you today?

Treatments are delivered at our JCI-accredited hospitals — Acıbadem International
We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.